Entero Healthcare Solutions Limited will conduct a virtual group meeting with analysts and institutional investors on September 29, 2026. The interaction is scheduled to begin at 2:00 pm and is organized by Arihant Capital Markets Ltd.

Meeting details

The company informed the stock exchanges that the session will be conducted in a virtual mode. Discussions during the call will be restricted to publicly available information. The company explicitly stated that no unpublished price-sensitive information (UPSI) is intended to be discussed during the interactions.

Regulatory compliance

This intimation is filed pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Sanu Kapoor, Vice President- Group General Counsel, Company Secretary & Compliance Officer, on September 22, 2026.

The company noted that changes to the schedule may occur due to exigencies on the part of participants or the company.

Entero Healthcare Solutions saw Surbhi Singh, acting as trustee for the Prasad Uno Family Trust, disclose the sale of 21.30 lakh shares via stock exchange mechanisms.

The transaction, executed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, comprised a bulk deal and a block deal.

Transaction details

The acquirer sold a total of 21.30 lakh shares, reducing their holding significantly. The sales occurred over two days in September 2026.

Shareholding pattern change

Prior to the sale, the trust held 34,55,420 shares, representing 7.94% of the total share capital. Following the disposal, the total holding dropped to 13,25,420 shares.

The disclosure confirmed that the acquirer does not belong to the promoter or promoter group of the target company. The total equity share capital of Entero Healthcare Solutions remains ₹43.52 crore, comprising 4,35,23,072 equity shares of face value ₹10 each.